Fresenius Kabi
Fresenius Kabi is a global healthcare provider focused on lifesaving medicines and technologies, committed to enhancing patient care for critically and chronically ill individuals.
Company facts
- Founded
- 1999
- Headquarters
- Germany
- CEO
- Pierluigi Antonelli
About
Fresenius Kabi is a global healthcare company dedicated to improving the lives of critically and chronically ill patients. Established in 1999, we are part of the larger Fresenius Group that has over 100 years of experience in healthcare. Our company is committed to providing high-quality medicines and technologies for infusion, transfusion, and clinical nutrition. With more than 43,000 employees operating in over 100 countries, we strive to deliver innovative and effective solutions that enhance patient care. Our mission encompasses not only providing essential medications but also fostering advancements in the healthcare system. Each year, we impact the lives of approximately 450 million patients. Our portfolio includes a diverse range of products such as biosimilars, IV therapies, and parenteral nutrition solutions. As we move forward, our Vision 2026 initiative aims to improve efficiencies in therapy and care, ensuring accessibility to high-quality healthcare for all. Fresenius Kabi's ongoing commitment to sustainability, ethics, and responsible management drives us to meet the needs of healthcare professionals and patients alike.